Case Study Details

  • Home
  • CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED Engaging and Responding to Your Stakeholders

CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED Engaging and Responding to Your Stakeholders

The Challenge

China Traditional Chinese Medicine is a pharmaceutical company that specialises in traditional Chinese medicine. Spearheading China’s efforts to expand the TCM industry around the world and with the introduction of strategic investors, the Company realised the importance of ESG reporting by identifying the risks and potential of its sustainability issues, which strengthened its appeal to international investors. CTCM’s priority was to properly convey its efforts in engaging and, more importantly, responding to its stakeholders.

Our Approach

First, a thorough stakeholder engagement process involving over 1,000 effective surveys was conducted to understand perspectives from the Company’s key stakeholder groups including suppliers, investors, employees, customers, etc. Then, we conducted on-site inspections to understand China TCM’s production and operation processes and validated material ESG issues with the management. Lastly, we identified the material topics in order to adhere to GRI Standards, communicating relevance of their business to the broader international audience.

Outcome

Backed by a rigorous and comprehensive stakeholder engagement process, we helped craft a report that reflects CTCM’s thorough understanding of risks and opportunities of the emerging TCM industry, as well as demonstrating alignment between its operations and ESG performance.